期刊
PHARMACEUTICAL RESEARCH
卷 26, 期 3, 页码 657-666出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-008-9774-1
关键词
cationic polymer; gene therapy; polymeric carrier; small interfering RNA
资金
- Korea Healthcare technology RD Project
- Ministry of Health and Welfare, Republic of Korea [A080919]
- Nano-Biotechnology Project (Regenomics)
- Ministry of Science and Technology, Republic of Korea [850-20080090]
- National Institute of Health, USA (NIH) [CA 107070]
- NATIONAL CANCER INSTITUTE [R01CA107070] Funding Source: NIH RePORTER
Sequence-specific gene silencing using small interfering RNA (siRNA) provides a potent and specific method for gene expression, thus is now being evaluated in clinical trials as a novel therapeutic strategy. As a results, there has been a significant surge of interest in the application of siRNA in therapeutics as a means of silencing the specific gene function. However, for siRNA technology to be valuable and effective, the development of efficient siRNA delivery strategy is essential for improving biological activities such as stability, cellular uptake, sequence-specificity, devoid of nonspecific knockdown and toxic side effects. Accordingly, a number of delivery systems, both viral and nonviral, have been reported and some of them successfully used for the introduction of siRNA into cells both in vitro and in vivo. Here, we discuss the current understanding of synthetic siRNA delivery mechanism and strategies of siRNA delivery by non-viral polymeric vehicles which are currently used in vitro and in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据